User Reviews
Do you care about money or consumer rights? Visit this site
The Consumerist is one of the few sites with the balls to lay it all on the line - the good, the bad, and the ugly. They care about setting the record straight and protecting consumer rights, and they Read more...
Filter reviews
04/11/2010
Better Be Nimble
"I am not sure who submitted this 'interview' on RPC, or how, why it was done now, etc, all I know is it has a biomedreports press release stamp on it: http://finance.yahoo.com/news/Radient-Pharmaceuticals-iw-3523703459.html?x=0&.v=1 RPC does have a FDA approved test....almost 2 years ago. Th Read more...
This website is great if you want to put your money at risk. I still remember when they promote really bad Positron corporation through emails and sms saying that a big partnership was coming. The stock went up at least 20 cents per share reaching the .30/ .31. Positron went to Nasdaq to announce t Read more...
01/29/2011
Great Content & Easy Navigation
"BioMed Reports provides information on biotech and healthcare sectors of the stock market. Here is what is good on their site: - clean layout and easy to navigate - great information with sources and easy to read formats - lots of ways to sign-up for information as it comes (email, twitters) - Read more...
12/30/2010
Pathetic picks !!!
"I subscribed for a yearly membership and got burned a lot. Really horrible picks and 96% losers. Their picks are up for like 2hrs after their alert or may be a day and then it blows on your face. Biorunup has a better FDA calendar and it is free. Please do not follow these guys."
11/28/2010
The hit and run
these guys post research articles and alerts. Sometimes the same stuff on the same stock mulitple times after a period of months as everyone forgets. They'll run up stocks like PSID which will trade 20k shares one day then all of the sudden just out of nowhere has 1 million. It gets people excited Read more...
11/28/2010
good for the calendar but don't follow their recommendations
"i invested in some of their editorialized ideas and was very disappointed. biomedical/pharmaceutical business is pretty tough on investors because success depends on factors that are difficult for non-FDA people to assess, the FDA calendar is often very murky. worse, some companies put out fakey Read more...
Tim Sykes taught me to take everything these guys publish with a grain of salt. When they talk about the next big pharma company, I do research of my own and it normally contradicts everything they have to say about it. Tim is right to not believe most things they have to say. While everyone is due Read more...
In long term period they have the worst track record with their pick. Usually they attract investors by buyout rumors. Look at their last picks: VRML was suggested to take long position on Aug 17 at 6.50ish per share and several articles covering POSC to encourage investors to take long position on Read more...
- 1
- 2
- 3